JPRN-UMIN000009822招募中2 期
Randomized phase II trial of neoadjuvant Chemotherapy with Gemcitabine and S-1 vs. without neoadjuvant chemotherapy in patients with resectable pancreatic cancer - Randomized phase II trial of GS neoadjuvant therapy for patients with resectable pancreatic cancer (CAP-004)
Chiba study group of adjuvant chemotherapy for pancreatic cancer0 个研究点目标入组 74 人开始时间: 2013年1月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 74
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Inadequate physical condition for gemcitabine or S-1 treatmetn according to manufacture's instruction 2. Sever myelosuppression 3. Pregnancy, breast feeding, or women who desire to preserve fecundity 4. Sever renal dysfunction 5. Sever hepatic dysfunction 6. With other anticancer treatment 7. With flucitocine or warfarin potassium treatment 8. With pulmonary fibrosis 9. With history of radiation to lung field 10. Active infectious disease 11. Massive pleural effusion 12. With distant metastasis 13. Active malignancies other than pancreatic cancer 14. Severe angina, cardiac infurction within 3 months at the registration, and severe hear failure 15. Severe diabetes or hypertension 16. Severe mental disorder 17. Inadequate physical condition, as diagnosed by primary physician
研究者
相似试验
招募中
1 期
Bintrafusp alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma.retroperitoneal sarcomasMedDRA version: 20.0Level: LLTClassification code 10039494Term: Sarcoma NOSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10077289Term: Retroperitoneal sarcomaSystem Organ Class: 100000004864EUCTR2021-001085-37-FRInstitut Bergonié66
已完成
不适用
Randomized phase II study of neoadjuvant chemotherapy with or without letrozole for postmenopausal ER-positive/HER2-negative breast cancersPostmenopausal breast cancerJPRN-UMIN000008416Kobe Breast Cancer Oncology Group70
已完成
2 期
Randomized Phase II Study of Neoadjuvant Chemotherapy and Trastuzumab (Herceptin) for Operable Breast Cancer with Overexpression of HER2Breast CancerJPRN-UMIN000000651Office for cordination of Herceptin trial100
已完成
2 期
A randomized phase II trial of adjuvant Chemotherapy with Gemcitabine alone, S-1 alone, versus gemcitabine and S-1 in patients with resected pancreatic cancerIncasive ductal carcinoma of pancreas with macroscopic complete resectionJPRN-UMIN000002000Chiba study group of adjuvant chemotherapy for pancreatic cancer96
已完成
2 期
A randomized phase II trial of adjuvant chemotherapy with UFT/LV versus S-1 following curative resection for stage III colorectal cancerstage III colorectal cancerJPRN-UMIN000001560Boso Clinical Oncology Group140